Gut dysbiosis and detection of "Live gut bacteria" in blood of Japanese patients with type 2 diabetes

Diabetes Care

Volumn 37, Issue 8, 2014, Pages 2343-2350

  Sato, Junko ^a   Kanazawa, Akio ^a   Ikeda, Fuki ^a   Yoshihara, Tomoaki ^a   Goto, Hiromasa ^a   Abe, Hiroko ^a   Komiya, Koji ^a   Kawaguchi, Minako ^a   Shimizu, Tomoaki ^a   Ogihara, Takeshi ^a   Tamura, Yoshifumi ^a   Sakurai, Yuko ^a   Yamamoto, Risako ^a   Mita, Tomoya ^a   Fujitani, Yoshio ^a   Fukuda, Hiroshi ^a   Nomoto, Koji ^b   Takahashi, Takuya ^b   Asahara, Takashi ^b   Hirose, Takahisa ^c   Nagata, Satoru ^a,d   Yamashiro, Yuichiro ^a   Watada, Hirotaka ^a   more..

^a JUNTENDO UNIVERSITY   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; METFORMIN;

ADULT; ARTICLE; ATOPOBIUM; BACTERIAL COUNT; BACTERIAL TRANSLOCATION; BACTERIUM DETECTION; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CONTROLLED STUDY; DIABETIC PATIENT; DYSBIOSIS; FECES ANALYSIS; FECES MICROFLORA; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; INTESTINE FLORA; JAPANESE (PEOPLE); LACTOBACILLUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LIVE GUT BACTERIUM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVOTELLA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SYSTEMIC CIRCULATION; AGED; BACTEREMIA; BLOOD; CASE CONTROL STUDY; COMPLICATION; FECES; INTESTINE; JAPAN; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BACTEREMIA; BLOOD; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DYSBIOSIS; FECES; FEMALE; HUMANS; INTESTINES; JAPAN; MALE; MICROBIOTA; MIDDLE AGED;

EID: 84904966070     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2817     Document Type: Article

References (35)

1. Kau AL, Ahern PP, Griffin N.W., Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature 2011; 474: 327-336
2. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489: 242-249
3. Kootte RS, Vrieze A, Holleman F., et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 2012; 14: 112-120
4. Cani PD, Bibiloni R, Knauf C., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481
5. Turnbaugh PJ, Ley RE, Mahowald M.A., Magrini V., Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031
6. Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterology 2009; 136: 1476-1483
7. Koeth RA, Wang Z, Levison B.S., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013; 19: 576-585
8. Karlsson FH, Fak F, Nookaew I., et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun 2012; 3: 1245
9. Tang WH, Wang Z, Levison B.S., et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368: 1575-1584
10. Cani PD, Amar J, Iglesias M.A., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772
11. Cani PD, Delzenne NM The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009; 15: 1546-1558
12. Everard A, Cani PD Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol 2013; 27: 73-83
13. Cani PD, Osto M, Geurts L., Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012; 3: 279-288
14. Blumberg R, Powrie F. Microbiota, disease, and back to health: a metastable journey. Sci Transl Med 2012; 4: 137rv7
15. Lozupone CA, Stombaugh JI, Gordon J.I., Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489: 220-230
16. Whiting DR, Guariguata L, Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311-321
17. Amar J, Serino M, Lange C., et al.; D.E.S.I.R. Study Group. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 2011; 54: 3055-3061
18. Matsuda K, Tsuji H, Asahara T., Kado Y, Nomoto K. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol 2007; 73: 32-39
19. Matsuda K, Tsuji H, Asahara T., Matsumoto K, Takada T, Nomoto K. Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 2009; 75: 1961-1969
20. Sakaguchi S, Saito M, Tsuji H., et al. Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia. J Clin Microbiol 2010; 48: 1624-1628
21. Ohigashi S, Sudo K, Kobayashi D., et al. Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig Dis Sci 2013; 58: 1717-1726
22. Sasaki S, Yanagibori R, Amano K. Self-administered diet history questionnaire developed for health education: a relative validation of the test-version by comparison with 3-day diet record in women. J Epidemiol 1998; 8: 203-215.
23. Kobayashi S, Murakami K, Sasaki S., et al. Comparison of relative validity of food group intakes estimated by comprehensive and brieftype self-administered diet history questionnaires against 16 d dietary records in Japanese adults. Public Health Nutr 2011; 14: 1200-1211
24. Serrano M, Moreno-Navarrete JM, Puig J., et al. Serum lipopolysaccharide-binding protein as a marker of atherosclerosis. Atherosclerosis 2013; 230: 223-227
25. Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5: e9085
26. Qin J, Li Y, Cai Z., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490: 55-60
27. Bergman EN. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 1990; 70: 567-590
28. Tolhurst G, Heffron H, Lam Y.S., et al. Shortchain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012; 61: 364-371
29. Fukuda S, Toh H, Hase K., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011; 469: 543-547
30. Yadav H, Lee JH, Lloyd J, Walter P., Rane SG. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem 2013; 288: 25088-25097
31. Muta T, Takeshige K. Essential roles of CD14 and lipopolysaccharide- binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. Eur J Biochem 2001; 268: 4580-4589.
32. Amar J, Chabo C, Waget A., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011; 3: 559-572.
33. Liew FY, Xu D, Brint E.K., O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005; 5: 446-458
34. Tang CH, Hsu CJ, Yang W.H., Fong YC. Lipoteichoic acid enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, PKCdelta and c-Src dependent pathways. Biochem Pharmacol 2010; 79: 1648-1657
35. Long EM, Millen B, Kubes P., Robbins SM. Lipoteichoic acid induces unique inflammatory responses when compared to other toll-like receptor 2 ligands. PLoS One 2009; 4: e5601